References
- Bretnall AE, Clarke GS. Metformin hydrochloride. In: Florey K, ed. Analytical profiles of drug substance. New York: Academic Press; 1998:243–293
- Desai D, Wong B, Huang Y, et al. Surfactant-mediated dissolution of metformin hydrochloride tablets: wetting effects versus ion pairs diffusivity. J Pharm Sci 2014;103:920–926
- Serajuddin AT, Rosoff M. pH-Solubility profile of papaverine hydrochloride and its relationship to the dissolution rate of sustained-release pellets. J Pharm Sci 1984;73:1203–1208
- Serajuddin AT, Jarowski CI. Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts. II: salicylic acid, theophylline, and benzoic acid. J Pharm Sci 1985;74:148–154
- Serajuddin AT, Jarowski CI. Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical bases and their hydrochloride salts. I: Phenazopyridine. J Pharm Sci 1985;74:142–147
- Gould PL. Salt selection for basic drugs. Int J Pharm 1986;33:201–217
- Thoma K, Zimmer T. Retardation of weakly basic drugs with diffusion tablets. Int J Pharm 1990;58:197–202
- Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc 1897;19:930–934
- Cussler EL. Diffusion: mass transfer in fluid systems. 2nd ed. Cambridge, UK: Cambridge University Press; 1997
- Diebold S. Physiological parameters relevant to dissolution testing. In: Jennifer D, Johannes K, eds. Hydrodynamic considerations. Boca Raton (FL): Taylor and Francis; 2005:127–191
- Zhao N, Augsburger L. Functionality comparison of 3 classes of superdisintegrants in promoting aspirin tablet disintegration and dissolution. AAPS PharmSciTech 2005;6:E634–E640
- Tanuwijaya J, Karsono. The effects of crospovidone and croscarmellose sodium as superdisintegrants on the characteristics of piroxicam nanoparticle ODT (orally disintegrating tablets). Int J PharmTech Res 2013;5:1590–1597
- Huang WX, Desai M, Tang Q, et al. Elimination of metformin-croscarmellose sodium interaction by competition. Int J Pharm 2006;311:33–39
- Marroum PJ. The role of dissolution from a regulatory perspective. Am Pharm Rev 2002;5:24–28
- General chapter <1090> Assesment of drug product performance-bioavailabiliy, bioequivalence, and dissolution. The United States Pharmacopoeial Convention. August 2011;USP 34:618–623
- Crison J, Timmins P, Keung A, et al. Biowaiver approach to Biopharmaceutics Classification System Class 3 compound metformin hydrochloride using in silico modeling. J Pharm Sci 2012;5:1773–1782